Many patients or their survivors are filing a Pradaxa Lawsuit after the drug has caused serious and life-threatening injuries
Since being approved by the US Food and Drug Administration (FDA) on October 19th, 2010, Pradaxa, the first drug approved as an alternative to the anticoagulant warfarin, Pradaxa has been under serious review by the FDA due to post market reports of severe and possibly deadly bleeding in patients that have taken the anticoagulant. As a result, patients (or their families) that have taken Pradaxa and have suffered a bleeding event are filing claims against the drug manufacturer, Boehringer Ingelheim. For more information on whether or not you might have a claim, fill out the contact form on this page or call.
What is Pradaxa?
Pradaxa, which is manufactured by Boehringer Ingelheim, is in a class of anticoagulant medications called direct thrombin inhibitors. Pradaxa may reduce the risk of strokes and blood clots in patients with [...]